Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Withdrawn 4Terminated 2Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Peutz-Jeghers Syndrome 1Pancreatic Neoplasms 1Intraductal Papillary Mucinous Neoplasms 1Diabetes Mellitus 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Interventional × Secretin × Clear all
NCT00587132 2013-06-24

Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma

Mayo Clinic

Phase 1/2 Terminated
4 enrolled 2 charts
Gastrointestinal

Diabetes Mellitus, Pancreatic Neoplasms, Peutz-Jeghers Syndrome

NCT00621556 2009-01-29

Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas

Massachusetts General Hospital

Phase 1 Terminated
2 enrolled

Intraductal Papillary Mucinous Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡